Product NDC: | 24090-473 |
Proprietary Name: | Inderal |
Non Proprietary Name: | propranolol hydrochloride |
Active Ingredient(s): | 120 mg/1 & nbsp; propranolol hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 24090-473 |
Labeler Name: | Akrimax Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA018553 |
Marketing Category: | NDA |
Start Marketing Date: | 19830419 |
Package NDC: | 24090-473-88 |
Package Description: | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24090-473-88) |
NDC Code | 24090-473-88 |
Proprietary Name | Inderal |
Package Description | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (24090-473-88) |
Product NDC | 24090-473 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | propranolol hydrochloride |
Dosage Form Name | CAPSULE, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 19830419 |
Marketing Category Name | NDA |
Labeler Name | Akrimax Pharmaceuticals, LLC |
Substance Name | PROPRANOLOL HYDROCHLORIDE |
Strength Number | 120 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |